Keyword: Polypharmacy
1 result found.
Review Article
International Journal of Evidence-Based Medicine, 1(4), 2026, jebm018, https://doi.org/10.63946/jebm/19983
ABSTRACT:
Background: Diabetes mellitus and hypertension frequently coexist, and adults with both conditions often require multiple medicines, increasing the risk of medication burden, poor adherence, and suboptimal disease control.
Objective: To synthesise evidence on the patterns, determinants, and interventions associated with rational antidiabetic and antihypertensive medication use among adults with coexisting diabetes and hypertension, and to propose a conceptual framework.
Methods: Following PRISMA 2020, PubMed, ScienceDirect, and Google Scholar (first 300 records) were searched for English-language studies published from January 2015 to July 2026. Quality was assessed using the Kmet criteria, and findings were synthesised narratively.
Results: Thirteen studies were included (five intervention, six cross-sectional, two qualitative), with quality scores of 85.7–100%; 11 were from low- and middle-income countries, and six enrolled mixed populations without separate results for the comorbid subgroup. All five interventions were pharmacist-led, and all four with extractable results improved at least one adherence measure, whereas effects on blood pressure and glycaemic control were inconsistent. Medication burden, limited knowledge, beliefs about medicines, affordability, and inadequate follow-up were recurring barriers. No study evaluated deprescribing or provider-focused interventions. Findings were organised into a six-component conceptual framework (ADHERE), in which deprescribing and provider support remain untested hypotheses.
Conclusion: Pharmacist-led education and follow-up were associated with improved adherence, but evidence on clinical outcomes and prescribing quality is limited. ADHERE is unvalidated and requires consensus and feasibility testing before implementation.
Objective: To synthesise evidence on the patterns, determinants, and interventions associated with rational antidiabetic and antihypertensive medication use among adults with coexisting diabetes and hypertension, and to propose a conceptual framework.
Methods: Following PRISMA 2020, PubMed, ScienceDirect, and Google Scholar (first 300 records) were searched for English-language studies published from January 2015 to July 2026. Quality was assessed using the Kmet criteria, and findings were synthesised narratively.
Results: Thirteen studies were included (five intervention, six cross-sectional, two qualitative), with quality scores of 85.7–100%; 11 were from low- and middle-income countries, and six enrolled mixed populations without separate results for the comorbid subgroup. All five interventions were pharmacist-led, and all four with extractable results improved at least one adherence measure, whereas effects on blood pressure and glycaemic control were inconsistent. Medication burden, limited knowledge, beliefs about medicines, affordability, and inadequate follow-up were recurring barriers. No study evaluated deprescribing or provider-focused interventions. Findings were organised into a six-component conceptual framework (ADHERE), in which deprescribing and provider support remain untested hypotheses.
Conclusion: Pharmacist-led education and follow-up were associated with improved adherence, but evidence on clinical outcomes and prescribing quality is limited. ADHERE is unvalidated and requires consensus and feasibility testing before implementation.